Lecture on recombinant DNA technology

-

This lecture is about Recombinant DNA technology presented by Rufia Abbas, she is from Gilgit, Pakistan.
For video:


For slides:

Comments

Post a Comment

Popular posts from this blog

Hydrogels

-
Image
By: Batool Murtaza Abstract Hydrogels have been around for almost half a century, and one of the oldest recordings of crosslinked hydroxyethyl methacrylate (HEMA) hydrogels dates back to the 1950s. Hydrogels continue to intrigue material scientists and biological researchers today, and significant progress has been made in terms of formulations and applications. Hydrogels are a type of material that consists of a self-supporting, water-swollen three-dimensional (3D) viscoelastic network that allows molecules and cells to diffuse and adhere. Hydrogels, on the other hand, have recently received a lot of attention for their usage in a wide range of biological applications, including cell therapies, wound healing, cartilage/bone regeneration, and medication sustained release. This is due to their biocompatibility and physical qualities that are similar to those of natural tissue. Based on ancient and new papers in this subject, this study attempts to provide an overview ...
Read more

Innovations in Vaccinology: The Rise of Recombinant Genetic Shields

-
Image
Immune protection against infectious diseases is a crucial objective in both human and animal health. Currently, the focus of the vaccine landscape is primarily on COVID-19, which has required an unprecedented global effort to develop and deploy vaccines rapidly. Consequently, vaccination has become a dominant subject in scientific literature, and detailed discussions on specific immunization strategies and vaccine-induced immune responses are widespread in the media. This situation has underscored the challenges posed by emerging viral pandemics and the need for a universal approach to vaccine development, regardless of the pathogen-host combination. Traditional vaccine formulations, such as inactivated or attenuated versions of the whole infectious agent, have faced limitations, such as potential safety risks associated with chemical inactivation or the risk of reverting to virulence with attenuated strains. As a result, there is a growing interest in recombinant subunit vaccines. ...
Read more

miRNA-Based Therapies: Revolutionizing Cancer Treatment Strategies

-
Image
Micro RNAs (miRNAs) are small non-coding RNA molecules that play a pivotal role in regulating gene expression post-transcriptionally. Since their discovery in 1993, miRNAs have been identified as key players in various cellular processes, including development, proliferation, differentiation, apoptosis, and stress response [1] . In recent years, miRNAs have gained significant attention in the field of cancer research due to their involvement in tumorigenesis, metastasis, and treatment resistance. This article delves into the intricate relationship between miRNAs and cancer, highlighting their potential as therapeutic targets and exploring the challenges and opportunities of utilizing miRNA-based therapies. miRNAs function by binding to complementary sequences within the 3' untranslated regions (UTRs) of target mRNAs, leading to mRNA degradation or translational repression. This intricate interaction allows miRNAs to fine-tune the expression of numerous genes, ultimately influe...
Read more